This page is marked NOINDEX and hidden from search engines: fails the stub criteria, missing: investor relationships, two agreeing sources.

TCM Life Science Form D (2026)

TCM Life Science reported $16,666 raised in an SEC Form D filed on 2026-10-26.

Company
TCM Life Science
Round type
Form D
Date
2026-10-26
Amount
$16.67K
Industry
Biotechnology
Location
Delaware

Summary

The SEC Form D for TCM Life Science, filed on 2026-10-26, reports $16,666 raised. The legal name on the form is TCM Life Science Inc.. The form does not name the purchasers. Filing: https://www.sec.gov/Archives/edgar/data/2160964/000216096426000001/0002160964-26-000001-index.htm

The offering amount is indefinite and is not stored as a number. The page stores Delaware and does not store the issuer city as a headquarters. EDGAR lists this as the only Form D. This is the issuer's first Form D.

This page is not indexed by search engines yet because the filing does not name the purchasers.

Investors

Sources

Last verified:

  1. https://www.sec.gov/Archives/edgar/data/2160964/000216096426000001/0002160964-26-000001-index.htm
    Type: sec filing. Accessed 2026-10-27.
    SEC Form D for TCM Life Science Inc. EDGAR filing date 2026-10-26. Signed 2026-10-26 by Ya-Chun Wang, President. First sale 2026-10-12. Total amount sold $16,666. The offering amount is indefinite and is not stored as a number. 2 investors already invested. Issuer address city is Newark, Delaware. Jurisdiction on the form: Delaware. Year of incorporation on the form: 2026. The form does not name the purchasers or a round type. Street addresses and phone numbers are not published. The form's security types are equity. EDGAR lists this as the only Form D. This is the issuer's first Form D.
  2. https://buttondown.com/raisetrack/archive/raise-track-update-2026-10-27/
    Type: other verified public source. Accessed 2026-10-27.
    Raise Track Update for 2026-10-27, Section 3. Lists TCM Life Science in Delaware, industry Biotechnology, amount raised $16,666.